DE602008002692D1 - Topische antibiotische zusammensetzung zur prävention von lyme-borreliose - Google Patents

Topische antibiotische zusammensetzung zur prävention von lyme-borreliose

Info

Publication number
DE602008002692D1
DE602008002692D1 DE602008002692T DE602008002692T DE602008002692D1 DE 602008002692 D1 DE602008002692 D1 DE 602008002692D1 DE 602008002692 T DE602008002692 T DE 602008002692T DE 602008002692 T DE602008002692 T DE 602008002692T DE 602008002692 D1 DE602008002692 D1 DE 602008002692D1
Authority
DE
Germany
Prior art keywords
prevention
antibiotic composition
lyme borreliosis
topical antibiotic
borrelia burgdorferi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602008002692T
Other languages
English (en)
Inventor
Gustave Huber
Uta Huettenes
Bidder Caroline Roosens-Von
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IXODES GmbH
Original Assignee
IXODES GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IXODES GmbH filed Critical IXODES GmbH
Publication of DE602008002692D1 publication Critical patent/DE602008002692D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE602008002692T 2007-07-25 2008-07-24 Topische antibiotische zusammensetzung zur prävention von lyme-borreliose Active DE602008002692D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07113143 2007-07-25
PCT/EP2008/059696 WO2009013331A1 (en) 2007-07-25 2008-07-24 Topical antibiotic composition for the prevention of lyme disease

Publications (1)

Publication Number Publication Date
DE602008002692D1 true DE602008002692D1 (de) 2010-11-04

Family

ID=39149162

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602008002692T Active DE602008002692D1 (de) 2007-07-25 2008-07-24 Topische antibiotische zusammensetzung zur prävention von lyme-borreliose

Country Status (15)

Country Link
US (2) US8710019B2 (de)
EP (1) EP2079441B1 (de)
JP (1) JP2010534221A (de)
AT (1) ATE481964T1 (de)
AU (1) AU2008280131B9 (de)
CA (1) CA2694403C (de)
CY (1) CY1110971T1 (de)
DE (1) DE602008002692D1 (de)
DK (1) DK2079441T3 (de)
ES (1) ES2349906T3 (de)
HR (1) HRP20100699T1 (de)
PL (1) PL2079441T3 (de)
PT (1) PT2079441E (de)
SI (1) SI2079441T1 (de)
WO (1) WO2009013331A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT106679B (pt) 2012-11-27 2015-03-25 Hovione Farmaciencia Sa Formulações tópicas de tetraciclinas, sua preparação e usos
CN107148480A (zh) * 2014-05-09 2017-09-08 张颖 对伯氏疏螺旋体的新型抗病毒活性的鉴定
JP6777734B2 (ja) 2015-06-10 2020-10-28 ピードモント アニマル ヘルス インコーポレイテッド 注射可能な抗生物質製剤及びその使用
EP3252470B1 (de) 2016-06-03 2020-07-29 Te?ted Oy Verfahren und fester träger zum nachweis von durch zecken übertragenen mikroben in einer biologischen probe

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1090253A (en) * 1976-11-01 1980-11-25 Edward D. Thompson Anti-acne composition
CA1165240A (en) * 1980-07-09 1984-04-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions
WO1998043673A1 (en) * 1997-03-31 1998-10-08 Johnson & Johnson Consumer Companies, Inc. Solvent system for enhanced penetration of pharmaceutical compounds
US7179475B1 (en) * 1998-12-04 2007-02-20 Johnson & Johnson Consumer Companies, Inc. Anhydrous topical skin preparations
US6239113B1 (en) * 1999-03-31 2001-05-29 Insite Vision, Incorporated Topical treatment or prevention of ocular infections
US6914051B1 (en) * 2000-06-28 2005-07-05 David M Allen Penetrating antibiotic gel for soft tissue diseases
US6589568B2 (en) * 2001-02-16 2003-07-08 Nurad, Inc. Therapeutic body lotion containing alkali metal hypohalite
NZ532074A (en) * 2001-11-06 2006-02-24 Maxim Pharm Inc Compositions for the treatment of infectious diseases
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same

Also Published As

Publication number Publication date
CY1110971T1 (el) 2015-06-11
AU2008280131B9 (en) 2014-11-13
CA2694403C (en) 2013-09-24
PL2079441T3 (pl) 2011-02-28
EP2079441B1 (de) 2010-09-22
HRP20100699T1 (hr) 2011-01-31
JP2010534221A (ja) 2010-11-04
DK2079441T3 (da) 2010-12-13
AU2008280131A8 (en) 2010-03-04
CA2694403A1 (en) 2009-01-29
SI2079441T1 (sl) 2010-12-31
ATE481964T1 (de) 2010-10-15
WO2009013331A1 (en) 2009-01-29
ES2349906T3 (es) 2011-01-12
US8710019B2 (en) 2014-04-29
AU2008280131B2 (en) 2014-06-26
US20100130437A1 (en) 2010-05-27
PT2079441E (pt) 2010-11-19
EP2079441A1 (de) 2009-07-22
US20140194375A1 (en) 2014-07-10
US9610244B2 (en) 2017-04-04
AU2008280131A1 (en) 2009-01-29

Similar Documents

Publication Publication Date Title
EA200970581A1 (ru) Кристаллическое твёрдое основание разагилина
BRPI0922220B8 (pt) uso de compostos antibacterianos, composição farmacêutica e combinação compreendendo os mesmos
EA200901617A1 (ru) Борсодержащие молекулы небольшого размера
UA107783C2 (en) Isoindoline compounds for use in treating cancer
WO2010090860A3 (en) Methods and compositions for treating bacterial infection
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
GT200600520A (es) Agentes antibacterianos
BR112013026929A2 (pt) composição e método para intensificação de uma resposta imune
MX2019006362A (es) Una combinacion de inmunoconjugado y anticuerpo para usarse en el tratamiento de cancer.
MA32257B1 (fr) Hydroxymethyl pyrrolidines comme agonistes des recepteurs beta-3- adrenergiques.
BR112012011485A2 (pt) "composições e métodos para tratar náusea e vômito centralmente mediados".
WO2007143607A3 (en) Method of treating atrophic vaginitis
BRPI0807487A8 (pt) Uso de antagonistas de il-23 para o tratamento de infecção
CL2008000592A1 (es) Compuestos derivados de pirrol sustituido, supresores de la secrecion de acidos; composicion farmaceutica; y uso en el tratamiento o profilaxis en enfermedades tales como ulcera peptica, gastritis, esofagitis, entre otras.
BRPI0712607A8 (pt) métodos de tratamento de acidente vascular cerebral
DE602007010764D1 (en) Benzamidglucokinaseaktivatoren
TNSN08370A1 (en) Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX349886B (es) Moleculas de union anti-pseudomonas lectina pisum satinum (psl) y usos de las mismas.
BRPI0815920A2 (pt) Composto, composição farmacêutica, e, uso do composto.
EA201590871A1 (ru) Макроциклические антибиотики широкого спектра действия
BR112013000779A2 (pt) composições farmacêuticas de combinação, métodos de tratamento de paciente e uso de forma potencializada ativada de anticorpo para receptor at1 de angiotensina ii e forma potencializada ativada de anticorpo para sintase no endotelial
DE602008002692D1 (de) Topische antibiotische zusammensetzung zur prävention von lyme-borreliose
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
WO2013166282A3 (en) Methods and compositions for treating bacterial infection
EP4137511A4 (de) Neue zusammensetzung zur verwendung zur behandlung und prävention von infektionen durch covid-19 und andere coronaviren